Jasper Ridge Partners, L.P. - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
Jasper Ridge Partners, L.P. ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$324,736
-64.0%
303,492
-12.9%
0.02%
-66.7%
Q2 2023$901,968
-36.5%
348,2500.0%0.04%
-33.8%
Q1 2023$1,420,860
-18.7%
348,2500.0%0.07%
-34.6%
Q4 2022$1,748,215
-58.1%
348,250
+9.3%
0.10%
-62.7%
Q3 2022$4,169,000
+2.0%
318,7500.0%0.28%
+13.0%
Q2 2022$4,086,000
-13.9%
318,750
+2.4%
0.25%
+5.6%
Q1 2022$4,747,000
-13.6%
311,250
+0.3%
0.23%
+13.6%
Q4 2021$5,495,000
-15.7%
310,2500.0%0.21%
-29.2%
Q3 2021$6,521,000
+6.6%
310,2500.0%0.29%
-4.6%
Q2 2021$6,118,000
-31.8%
310,250
+0.5%
0.30%
-26.2%
Q1 2021$8,975,000
-4.1%
308,7500.0%0.41%
-0.2%
Q4 2020$9,354,000
+90.4%
308,7500.0%0.41%
+46.3%
Q3 2020$4,912,000
-19.4%
308,7500.0%0.28%
-32.9%
Q2 2020$6,095,000
+60.1%
308,7500.0%0.42%
+39.7%
Q1 2020$3,807,000
-32.9%
308,750
+0.6%
0.30%
-19.0%
Q4 2019$5,676,000
+17.1%
307,000
-12.3%
0.37%
+46.3%
Q3 2019$4,848,000
-5.1%
350,000
+0.3%
0.26%
+22.6%
Q2 2019$5,109,000349,0000.21%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,766,666$79,175,00044.14%
Ponoi II Management, LLC 1,298,908$27,303,00040.46%
Column Group LLC 15,396,116$323,626,00036.81%
Ponoi Management, LLC 1,298,908$27,303,00024.24%
Euclidean Capital LLC 832,274$17,494,0008.50%
StepStone Group LP 1,573,357$33,072,0002.14%
Octagon Capital Advisors LP 200,000$4,204,0001.04%
Redmile Group, LLC 2,505,118$52,658,0000.92%
BVF INC/IL 955,000$20,074,0000.78%
Boxer Capital, LLC 500,000$10,510,0000.37%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders